“…These findings are supported by previous reports showing that caveolin 1 and 2 expression is associated with highly aggressive tumours such as inflammatory breast carcinoma (Eynden, 2005), basal-like (Savage et al, , 2008) and triple-negative breast carcinoma (Shack et al, 2003;Tan et al, 2007;Savage et al, 2007Savage et al, , 2008. Aside from breast, the association between caveolin expression and poor patient outcome was noticed in other tissue tumours (Savage et al, , 2008, including prostate (Karam et al, 2007), lung ((Ho et al, 2008), and the central nervous system (Barresi et al, 2006).…”